Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Ovarian Neoplasms 1Hematologic Neoplasms 1Heart Failure 1Fallopian Tube Neoplasms 1Cardiomyopathies 1Brenner Tumor 1

Interventions

Standard of Care 2Rituximab 2Carvedilol 2sacubitril and valsartan sodium hydrate drug combination 1pegfilgrastim 1obinutuzumab 1empagliflozin 1dapagliflozin 1acalabrutinib 1Vincristine 1Vascular Stiffness 1Valsartan 1Specimen Handling 1Pulse Wave Analysis 1Prednisolone 1Practice Guidelines as Topic 1Palliative Care 1Nutrition Assessment 1Mesenchymal Stem Cell Transplantation 1Lenalidomide 1Health Information Exchange 1Exercise 1Eplerenone 1Electronic Health Records 1Electrocardiography 1Echocardiography 1Doxorubicin 1Dexrazoxane 1Cyclophosphamide 1Cardiac Resynchronization Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Heart Failure × Mesenchymal Stem Cell Transplantation × 1 year × Clear all
NCT02962661 2026-01-07

Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

M.D. Anderson Cancer Center

Phase 1 Recruiting
72 enrolled
Other hematologic neoplasm

Heart Failure, Cardiomyopathies, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡